このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Medtronic マネジメント
マネジメント 基準チェック /44
Medtronic'sの CEO はGeoff Marthaで、 Apr2020年に任命され、 の在任期間は 4.17年です。 の年間総報酬は$ 15.39Mで、 8.8%給与と91.2%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.004%を直接所有しており、その価値は$ 4.55M 。経営陣と取締役会の平均在任期間はそれぞれ3.4年と9.4年です。
主要情報
Geoff Martha
最高経営責任者
US$15.4m
報酬総額
CEO給与比率 | 8.8% |
CEO在任期間 | 4.2yrs |
CEOの所有権 | 0.01% |
経営陣の平均在職期間 | 3.4yrs |
取締役会の平均在任期間 | 9.4yrs |
経営陣の近況
Recent updates
Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Medtronic: Dark Clouds Are Clearing - Outperformance Ahead
Aug 14Return Trends At Medtronic (NYSE:MDT) Aren't Appealing
Aug 11Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth
Jul 15Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?
Jul 09Is Medtronic (NYSE:MDT) A Risky Investment?
Jun 21Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter
Jun 21Is Medtronic's Dividend In A Good Place?
Jun 14Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69
Jun 03Medtronic: Solid Q4 Earnings, Don't Fret About Guidance
May 26CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Apr 26 2024 | n/a | n/a | US$4b |
Jan 26 2024 | n/a | n/a | US$4b |
Oct 27 2023 | n/a | n/a | US$4b |
Jul 28 2023 | n/a | n/a | US$4b |
Apr 28 2023 | US$15m | US$1m | US$4b |
Jan 27 2023 | n/a | n/a | US$4b |
Oct 28 2022 | n/a | n/a | US$4b |
Jul 29 2022 | n/a | n/a | US$5b |
Apr 29 2022 | n/a | n/a | US$5b |
Jan 28 2022 | n/a | n/a | US$5b |
Oct 29 2021 | n/a | n/a | US$5b |
Jul 30 2021 | n/a | n/a | US$4b |
Apr 30 2021 | US$18m | US$1m | US$4b |
Jan 29 2021 | n/a | n/a | US$3b |
Oct 30 2020 | n/a | n/a | US$4b |
Jul 31 2020 | n/a | n/a | US$4b |
Apr 24 2020 | US$6m | US$905k | US$5b |
Jan 24 2020 | n/a | n/a | US$5b |
Oct 25 2019 | n/a | n/a | US$5b |
Jul 26 2019 | n/a | n/a | US$4b |
Apr 26 2019 | US$4m | US$693k | US$5b |
報酬と市場: Geoffの 総報酬 ($USD 15.39M ) は、 US市場 ($USD 13.55M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Geoffの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Geoff Martha (54 yo)
4.2yrs
在職期間
US$15,394,632
報酬
Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Chairman at Medtron...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Chairman of the Board & CEO | 4.2yrs | US$15.39m | 0.011% $ 11.5m | |
Executive VP & CFO | 8yrs | US$6.12m | 0.0051% $ 5.3m | |
Executive VP & President of Cardiovascular Portfolio | no data | US$5.36m | 0.0019% $ 2.0m | |
Executive VP & President of Global Regions | 9.4yrs | US$5.05m | 0.0024% $ 2.5m | |
Senior Vice President of Global Operations and Business Services | 7.7yrs | データなし | データなし | |
Senior VP | 3yrs | データなし | 0.0010% $ 1.1m | |
Senior VP and Chief Technology & Innovation Officer | less than a year | データなし | データなし | |
Senior VP and Chief Scientific & Medical Officer | 2.2yrs | データなし | データなし | |
VP & Head of Investor Relations | 9yrs | データなし | データなし | |
Executive VP | 2.3yrs | US$11.72m | 0.00084% $ 880.7k | |
Senior VP & Chief Communications Officer | 3.4yrs | データなし | データなし | |
Chief Human Resources Officer | less than a year | データなし | データなし |
3.4yrs
平均在職期間
59yo
平均年齢
経験豊富な経営陣: MDTの経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Chairman of the Board & CEO | 4.6yrs | US$15.39m | 0.011% $ 11.5m | |
Independent Director | 11.4yrs | US$365.01k | 0.0013% $ 1.4m | |
Independent Director | 17.4yrs | US$350.01k | 0.0033% $ 3.5m | |
Independent Director | 9.4yrs | US$385.01k | 0.0033% $ 3.4m | |
Lead Independent Director | 9.4yrs | US$410.01k | 0.0027% $ 2.9m | |
Independent Director | 24.4yrs | US$375.01k | 0.0059% $ 6.2m | |
Independent Director | 5.3yrs | US$370.01k | 0.00047% $ 492.8k | |
Independent Director | 10.4yrs | US$370.01k | 0.0010% $ 1.1m | |
Independent Director | 2yrs | US$294.37k | 0.00012% $ 125.8k | |
Independent Director | 3.8yrs | US$370.01k | 0.00031% $ 325.0k | |
Independent Director | less than a year | データなし | データなし |
9.4yrs
平均在職期間
64yo
平均年齢
経験豊富なボード: MDTの 取締役会 は 経験豊富 であると考えられます ( 9.4年の平均在任期間)。